Genetic Study of Kawasaki Disease

Imaniar Noor Faridah; Dyah Aryani Perwitasari; Wei Chiao Chang

doi:10.1007/978-981-19-2944-1_11

Genetic Study of Kawasaki Disease

Imaniar Noor Faridah, Dyah Aryani Perwitasari, Wei Chiao Chang

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

Kawasaki disease (KD) is a leading cause of acquired heart disease in children; however, the etiology of this disease is still unclear. Several genome-wide association studies (GWASs) indicated that genetic variations contribute to KD susceptibility and intravenous immunoglobulin (IVIG) responses. Application genetic risk score is another example of pharmacogenomics research for predicting IVIG unresponsiveness. High-throughput DNA sequencing technology has been developed on an unprecedented scale, and more and more genomic information will be available to understand the etiology and treatment of KD.

Original language	English
Title of host publication	Kawasaki Disease
Publisher	Springer Nature
Pages	103-116
Number of pages	14
ISBN (Electronic)	9789811929441
ISBN (Print)	9789811929434
DOIs	https://doi.org/10.1007/978-981-19-2944-1_11
Publication status	Published - Jan 1 2022

Keywords

Genetics
IVIG response
Kawasaki disease
Susceptibility

ASJC Scopus subject areas

General Medicine

Access to Document

10.1007/978-981-19-2944-1_11

Cite this

@inbook{4611741fa7714e8cac158aab8e653675,

title = "Genetic Study of Kawasaki Disease",

abstract = "Kawasaki disease (KD) is a leading cause of acquired heart disease in children; however, the etiology of this disease is still unclear. Several genome-wide association studies (GWASs) indicated that genetic variations contribute to KD susceptibility and intravenous immunoglobulin (IVIG) responses. Application genetic risk score is another example of pharmacogenomics research for predicting IVIG unresponsiveness. High-throughput DNA sequencing technology has been developed on an unprecedented scale, and more and more genomic information will be available to understand the etiology and treatment of KD.",

keywords = "Genetics, IVIG response, Kawasaki disease, Susceptibility",

author = "Faridah, {Imaniar Noor} and Perwitasari, {Dyah Aryani} and Chang, {Wei Chiao}",

note = "Publisher Copyright: {\textcopyright} The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd. 2022.",

year = "2022",

month = jan,

day = "1",

doi = "10.1007/978-981-19-2944-1_11",

language = "English",

isbn = "9789811929434",

pages = "103--116",

booktitle = "Kawasaki Disease",

publisher = "Springer Nature",

address = "Germany",

}

TY - CHAP

T1 - Genetic Study of Kawasaki Disease

AU - Faridah, Imaniar Noor

AU - Perwitasari, Dyah Aryani

AU - Chang, Wei Chiao

N1 - Publisher Copyright: © The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd. 2022.

PY - 2022/1/1

Y1 - 2022/1/1

N2 - Kawasaki disease (KD) is a leading cause of acquired heart disease in children; however, the etiology of this disease is still unclear. Several genome-wide association studies (GWASs) indicated that genetic variations contribute to KD susceptibility and intravenous immunoglobulin (IVIG) responses. Application genetic risk score is another example of pharmacogenomics research for predicting IVIG unresponsiveness. High-throughput DNA sequencing technology has been developed on an unprecedented scale, and more and more genomic information will be available to understand the etiology and treatment of KD.

AB - Kawasaki disease (KD) is a leading cause of acquired heart disease in children; however, the etiology of this disease is still unclear. Several genome-wide association studies (GWASs) indicated that genetic variations contribute to KD susceptibility and intravenous immunoglobulin (IVIG) responses. Application genetic risk score is another example of pharmacogenomics research for predicting IVIG unresponsiveness. High-throughput DNA sequencing technology has been developed on an unprecedented scale, and more and more genomic information will be available to understand the etiology and treatment of KD.

KW - Genetics

KW - IVIG response

KW - Kawasaki disease

KW - Susceptibility

UR - http://www.scopus.com/inward/record.url?scp=85169363587&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85169363587&partnerID=8YFLogxK

U2 - 10.1007/978-981-19-2944-1_11

DO - 10.1007/978-981-19-2944-1_11

M3 - Chapter

AN - SCOPUS:85169363587

SN - 9789811929434

SP - 103

EP - 116

BT - Kawasaki Disease

PB - Springer Nature

ER -

Genetic Study of Kawasaki Disease

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this